Opening book details…
About this Medicine article
1LB 5-year overall survival update from the X-ACT trial of capecitabine vs. 5-FU/LV as adjuvant treatment for stage-III colon cancer by C. Twelves; W. Scheithauer; J. McKendrick; M. Nowacki; J. Seitz; G. Van Hazel; A. Wong; E. Diaz-Rubio; J. Cassidy is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- C. Twelves; W. Scheithauer; J. McKendrick; M. Nowacki; J. Seitz; G. Van Hazel; A. Wong; E. Diaz-Rubio; J. Cassidy
- Publisher
- Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 1359-6349)
- Published
- 2007
- Language
- EN
- Field
- Medicine (Health Sciences)